Resumen:
font face="RealpageTIM11" size="1">
ABSTRACT In this work we evaluated the efficacy and safety of a bread formulation containing chitosan in dyslipidemic
type 2 diabetic subjects. For this purpose a total of 18 patients were allowed to incorporate to their habitual diets 120 g/day
of bread containing 2% (wt/wt) chitosan (chitosan group, n 5 9) or standard bread (control group, n 5 9). Before the study
and after 12 weeks on the modified diet, the following parameters were evaluated: body weight, plasma cholesterol, high-density
lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglyceride, and